Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Breast Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Neuroma 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Hereditary leiomyomatosis and renal cell cancer 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Agnosia 1

Interventions

Ropivacaine 2 Magnesium Sulfate 2 Fentanyl 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 ramosetron 1 Transdermal Patch 1 Tablets 1 Surveys and Questionnaires 1 Psilocybin 1 Pregabalin 1 Nefopam 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Ketoprofen 1 Ketamine 1 Injections, Subcutaneous 1 High-Energy Shock Waves 1 Control Groups 1 Capsaicin 1 Bupivacaine 1 Botulinum Toxins, Type A 1 Anesthetics, Local 1 Analgesics, Opioid 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Agnosia × Botulinum Toxins, Type A × Clear all

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡